Chia Tai Tianqing Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChia Tai Tianqing Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fosaprepitant dimeglumine	Fosaprepitant dimeglumine	2021-03-03		—
Fulvestrant	Fulvestrant	2020-02-07	2034	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

male breast neoplasms

,

type 1 diabetes mellitus

healthy volunteers/patients

,

inflammatory bowel diseases

,

intestinal diseases

,

rheumatoid arthritis

,

,

,

adenocarcinoma of lung

,

drug-related side effects and adverse reactions

,

meningeal carcinomatosis

,

gastrointestinal stromal tumors

,

cholangiocarcinoma

,

squamous cell carcinoma of head and neck

,

pancreatic neoplasms

,

t-cell lymphoma peripheral

,

t-cell lymphoma

,

,

uterine cervical neoplasms

,

biliary tract neoplasms

,

healthy volunteers/patients

,

large b-cell lymphoma diffuse

,

chemoradiotherapy

,

b-cell lymphoma

,

,

extranodal nk-t-cell lymphoma

,

neuroendocrine carcinoma

,

molecular targeted therapy

,

thoracic neoplasms

,

ovarian neoplasms

,

neuroendocrine tumors

,

,

brain neoplasms

,

,

multiple primary neoplasms

,

t-cell lymphoma cutaneous

,

microsatellite instability

,

mouth neoplasms

,

malignant mesothelioma

,

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

,

clear cell adenocarcinoma

,

adenomyoepithelioma

,

,

microsatellite repeats

,

immunoblastic lymphadenopathy

,

,

adoptive immunotherapy

,

respiratory tract diseases

,

,

precancerous conditions

,

aortic dissection

,

perioperative period

,

salivary gland neoplasms

,

unknown primary neoplasms

,

malignant fibrous histiocytoma

,

disorders of sex development

,

hemangiosarcoma

,

,

,

kidney neoplasms

,

,

oligodendroglioma

,

residual neoplasm

,

,

cutaneous malignant melanoma

,

appendiceal neoplasms

,

gallbladder neoplasms

,

lymphatic metastasis

,

head and neck neoplasms

,

airway obstruction

,

intensity-modulated radiotherapy

,

maintenance chemotherapy

,

small cell carcinoma

,

non-hodgkin lymphoma

,

follicular lymphoma

,

mantle-cell lymphoma

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

colorectal neoplasms

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

,

,

esophageal neoplasms

,

neoplasm metastasis

,

rectal neoplasms

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

small cell lung carcinoma

,

renal cell carcinoma

,

neoadjuvant therapy

,

,

colonic neoplasms

,

,

squamous cell neoplasms

,

,

endometrial neoplasms

,

gastrointestinal diseases

,

esophageal diseases

,

,

radiation pneumonitis

,

,

adjuvant chemotherapy

,

adjuvant radiotherapy

,

non-small-cell lung carcinoma

,

stomach neoplasms

,

,

,

,

breast neoplasms

,

hodgkin disease

,

triple negative breast neoplasms

,

thyroid neoplasms

,

thyroid diseases

,

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

catheter ablation

,

female genital neoplasms

,

abdominal neoplasms

,

,

venous thrombosis

,

hemophagocytic lymphohistiocytosis

,

,

,

,

gastrointestinal microbiome

,

acute kidney injury

,

tumor microenvironment

,

endometrioid carcinoma

,

colorectal neoplasms

,

stomach neoplasms

,

pancreatic neoplasms

,

esophageal squamous cell carcinoma

,

squamous cell carcinoma

,

squamous cell carcinoma of head and neck

,

large b-cell lymphoma diffuse

,

gastrointestinal neoplasms

,

thyroid neoplasms

,

breast neoplasms

,

,

neoplasm metastasis

,

,

rectal neoplasms

,

pheochromocytoma

,

urologic neoplasms

,

digestive system neoplasms

,

gastrointestinal stromal tumors

,

neuroendocrine tumors

,

small cell lung carcinoma

,

female genital neoplasms

,

,

uterine cervical neoplasms

,

neoplasms by histologic type

,

triple negative breast neoplasms

,

male breast neoplasms

,

essential tremor

,

head and neck neoplasms

,

,

gastrointestinal diseases

,

digestive system diseases

,

,

,

b-cell lymphoma

,

,

esophageal neoplasms

,

,

neoadjuvant therapy

,

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

hodgkin disease

,

squamous cell neoplasms

,

hypersensitivity

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

small cell carcinoma

,

thyroid diseases

pharmacokinetics

breast neoplasms

,

triple negative breast neoplasms

,

neoplasm metastasis

actinic keratosis

,

Efbemalenograstim alfa

,

non-small-cell lung carcinoma

,

,

febrile neutropenia

,

ovarian neoplasms

,

uterine cervical neoplasms

Aglatimagene besadenovec

prostatic neoplasms

,

ovarian neoplasms

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

esophageal neoplasms

,

urinary bladder neoplasms

,

uterine cervical neoplasms

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

breast neoplasms

1

2

3

4

5

6

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use